Georgina Long
Professor Georgina Long is a prominent Australian researcher and oncologist known for her groundbreaking work in immunotherapy for cancer treatment. Her recent study highlighted the promising potential of a specific drug to treat glioblastoma, a highly aggressive brain tumor, showing that it can effectively penetrate tumors and activate immune responses. Long's contributions to cancer research have earned her recognition, including being named 2024 Australian of the Year alongside her colleague.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Australia | 2 | 8.00 | 0.16% | +10% | 25,499,884 | 44,880 | $1,380,000 | 2,429$ |
| Totals | 2 | 25,499,884 | 44,880 | $1,380,000 | 2,429$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Georgina Long is a fellow medical researcher and was mentioned as the co-medical director with Richard Scolyer.
8
Australia:
Georgina Long is a fellow co-medical director at the Melanoma Institute Australia who proposed a risky experimental treatment for Richard Scolyer.
8
Australia:
Georgina Long was named joint 2024 Australian of the Year with Richard Scolyer.
8
Australia:
Professor Georgina Long, the 2024 joint Australian of the Year, is chair of Melanoma Medical Oncology and Translational Research at the University of Sydney.
9
Australia:
Georgina Long is a world-famous melanoma researcher linked to a healthy higher education system.
7
Australia:
Georgina Long has been honoured for her work with melanoma.
9
Australia:
Georgina Long is renowned for her groundbreaking research into melanoma and was the joint Australian of the Year in 2024.
9
Australia:
Professor Georgina Long is involved in pioneering immunotherapy treatments for melanoma and has collaborated with Richard Scolyer.
8
Australia:
Professor Georgina Long’s immunotherapy study paves way for clinical trial.
9